Caryl Baron - Sep 22, 2023 Form 4 Insider Report for SeaStar Medical Holding Corp (ICU)

Role
Interim CFO
Signature
/s/ Eric Schlorff, as attorney-in-fact
Stock symbol
ICU
Transactions as of
Sep 22, 2023
Transactions value $
$0
Form type
4
Date filed
11/29/2023, 04:14 PM
Previous filing
Sep 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICU Common Stock, par value $0.0001 per share Other $0 +15.1K +14.42% $0.00 120K Sep 22, 2023 Direct F1, F2
transaction ICU Common Stock, par value $0.0001 per share Award $0 +20.3K +16.97% $0.00 140K Nov 29, 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ICU Stock Option (Right to Buy) 16.6K Sep 22, 2023 Common Stock 16.6K $1.84 Direct F4
holding ICU Stock Option (Right to Buy) 4.8K Sep 22, 2023 Common Stock 4.8K $10.00 Direct F5
holding ICU Stock Option (Right to Buy) 19.7K Sep 22, 2023 Common Stock 19.7K $0.55 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents fully vested shares of common stock issued to the Reporting Person pursuant to the Issuer's equity incentive plan. The securities reported in this transaction were initially withheld by the Issuer to satisfy tax withholding obligations. The Issuer subsequently elected to satisfy the withholding obligations through an alternative method and returned these shares to the Reporting Person.
F2 Due to rounding errors, (i) the Form 4 filed for the Reporting Person on August 17, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 15, 2023 by 1 share, (ii) the Form 4 filed for the Reporting Person on September 12, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 31, 2023 by 1 share, and (iii) the Form 4 filed for the Reporting Person on September 19, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on September 15, 2023 by 1 share. These errors have been corrected on this Form 4.
F3 The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee.
F4 All options reported herein will vest, subject to continued service, on April 6, 2024, the first anniversary of the date of grant.
F5 The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from March 30, 2020 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from March 30, 2021.
F6 The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from January 1, 2021 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from January 1, 2022.